Literature DB >> 32511883

Tobacco smoke exposure in pediatric cystic fibrosis: A qualitative study of clinician and caregiver perspectives on smoking cessation.

Gabriela R Oates1, William T Harris1, Hector H Gutierrez1, Cathy Mims2, Sarah B Rutland1, Corilyn Ott3, Soumya J Niranjan4, Isabel C Scarinci5, Susan C Walley6.   

Abstract

OBJECTIVE: Tobacco smoke exposure has negative impacts on the lung health of children with cystic fibrosis (CF), yet evidence-based strategies for smoking cessation have not been tested with or tailored to CF caregivers. This qualitative study identified barriers and facilitators of smoking cessation in this population and outlined potential interventional approaches.
METHODS: We conducted semi-structured interviews with CF familial caregivers who were current or former smokers, and with members of the CF care team. We asked about experiences, practices, and prerequisites for a successful program. Interviews were recorded, transcribed verbatim, and coded by two investigators. Analysis used a thematic approach guided by the PRECEDE model, which identifies predisposing (intrapersonal), reinforcing (interpersonal), and enabling (structural) factors relevant to health behaviors and programs.
RESULTS: Seventeen interviews were conducted-eight with familial caregivers and nine with CF team members. Whereas caregivers provided greater insight into internal difficulties and motivators to quit smoking, clinicians offered more extensive input on barriers and solutions related to the clinical environment. Based on study recommendations, a successful tobacco cessation program should include (a) family education about the harms of smoke exposure for children with CF; (b) screening for exposure, ideally with biochemical verification; (c) access to trained tobacco counselors; (d) affordable pharmacotherapy; and (e) outpatient follow-up of those undergoing tobacco treatment.
CONCLUSION: This qualitative study revealed intrapersonal, interpersonal, and structural barriers to eliminating tobacco smoke exposure in children with CF, outlined opportunities to address these barriers, and made recommendations for a comprehensive tobacco cessation strategy.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  cystic fibrosis; qualitative methods; second-hand smoke; smoke exposure; smoking cessation; tobacco

Mesh:

Substances:

Year:  2020        PMID: 32511883      PMCID: PMC7686064          DOI: 10.1002/ppul.24879

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  37 in total

Review 1.  Real qualitative researchers do not count: the use of numbers in qualitative research.

Authors:  M Sandelowski
Journal:  Res Nurs Health       Date:  2001-06       Impact factor: 2.228

2.  Social disadvantage predicts growth outcomes in preadolescent children with cystic fibrosis.

Authors:  Dorene F Balmer; Joan I Schall; Virginia A Stallings
Journal:  J Cyst Fibros       Date:  2008-08-05       Impact factor: 5.482

3.  Parental Smoking Cessation: Impacting Children's Tobacco Smoke Exposure in the Home.

Authors:  Alice Little Caldwell; Martha S Tingen; Joshua T Nguyen; Jeannette O Andrews; Janie Heath; Jennifer L Waller; Frank A Treiber
Journal:  Pediatrics       Date:  2018-01       Impact factor: 7.124

4.  The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.

Authors:  M S Schechter; B J Shelton; P A Margolis; S C Fitzsimmons
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

5.  Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.

Authors:  Don B Sanders; Julia Emerson; Clement L Ren; Michael S Schechter; Ronald L Gibson; Wayne Morgan; Margaret Rosenfeld
Journal:  Ann Am Thorac Soc       Date:  2015-08

6.  When smokers quit: exposure to nicotine and carcinogens persists from thirdhand smoke pollution.

Authors:  Georg E Matt; Penelope J E Quintana; Joy M Zakarian; Eunha Hoh; Melbourne F Hovell; Melinda Mahabee-Gittens; Kayo Watanabe; Kathy Datuin; Cher Vue; Dale A Chatfield
Journal:  Tob Control       Date:  2016-09-21       Impact factor: 7.552

7.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

8.  Clinical Practice Policy to Protect Children From Tobacco, Nicotine, and Tobacco Smoke.

Authors:  Harold J Farber; Susan C Walley; Judith A Groner; Kevin E Nelson
Journal:  Pediatrics       Date:  2015-11       Impact factor: 7.124

9.  Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis.

Authors:  Benjamin T Kopp; Rohan Thompson; Jeeho Kim; Robert Konstan; Alejandro Diaz; Bennett Smith; Chandra Shrestha; Lynette K Rogers; Don Hayes; Dmitry Tumin; Frederick W Woodley; Octavio Ramilo; Don B Sanders; Judith A Groner; Asuncion Mejias
Journal:  Thorax       Date:  2019-01-19       Impact factor: 9.139

10.  Households contaminated by environmental tobacco smoke: sources of infant exposures.

Authors:  G E Matt; P J E Quintana; M F Hovell; J T Bernert; S Song; N Novianti; T Juarez; J Floro; C Gehrman; M Garcia; S Larson
Journal:  Tob Control       Date:  2004-03       Impact factor: 7.552

View more
  3 in total

Review 1.  Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies.

Authors:  Gabriela R Oates; Michael S Schechter
Journal:  Expert Rev Respir Med       Date:  2022-06-23       Impact factor: 4.300

2.  Cessation of smoke exposure improves pediatric CF outcomes: Longitudinal analysis of CF Foundation Patient Registry data.

Authors:  Gabriela R Oates; Elizabeth Baker; Joseph M Collaco; Steven M Rowe; Sarah B Rutland; Christopher M Fowler; William T Harris
Journal:  J Cyst Fibros       Date:  2021-07-17       Impact factor: 5.527

3.  Speaking of pandemics...

Authors:  Michael S Schechter
Journal:  J Cyst Fibros       Date:  2021-06-05       Impact factor: 5.482

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.